APO-SALVENT STERULES SOLUTION

Ország: Kanada

Nyelv: angol

Forrás: Health Canada

Aktív összetevők:

SALBUTAMOL (SALBUTAMOL SULFATE)

Beszerezhető a:

APOTEX INC

ATC-kód:

R03AC02

INN (nemzetközi neve):

SALBUTAMOL

Adagolás:

0.5MG

Gyógyszerészeti forma:

SOLUTION

Összetétel:

SALBUTAMOL (SALBUTAMOL SULFATE) 0.5MG

Az alkalmazás módja:

INHALATION

db csomag:

2.5 ML

Recept típusa:

Prescription

Terápiás terület:

SELECTIVE BETA 2-ADRENERGIC AGONISTS

Termék összefoglaló:

Active ingredient group (AIG) number: 0108887009; AHFS:

Engedélyezési státusz:

APPROVED

Engedély dátuma:

2001-05-11

Termékjellemzők

_Page 1 of 32_
PRODUCT MONOGRAPH
PR
APO-SALVENT RESPIRATOR SOLUTIONS
(SALBUTAMOL SULFATE SOLUTIONS BP)
PR
APO-SALVENT RESPIRATOR SOLUTION 50 MG IN 10 ML (5 MG/ML SALBUTAMOL)
PR
APO-SALVENT STERULES 1.25 MG IN 2.5 ML (0.5 MG/ML SALBUTAMOL)
PR
APO-SALVENT STERULES 2.5 MG IN 2.5 ML (1 MG/ML SALBUTAMOL)
PR
APO-SALVENT STERULES 5.0 MG IN 2.5 ML (2 MG/ML SALBUTAMOL)
BRONCHODILATOR,
Β
2
-ADRENERGIC STIMULANT
APOTEX INC.
150 SIGNET DRIVE
TORONTO, ONTARIO
DATE OF REVISION:
M9L 1T9
March 16, 2020
CONTROL # 236795
_Page 2 of 32_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................................................
3
SUMMARY PRODUCT INFORMATION
..................................................................................................................
3
INDICATIONS AND CLINICAL USE
........................................................................................................................
3
CONTRAINDICATIONS
.............................................................................................................................................
3
WARNINGS AND PRECAUTIONS
............................................................................................................................
4
ADVERSE REACTIONS
.............................................................................................................................................
7
DRUG INTERACTIONS
..............................................................................................................................................
8
DOSAGE AND ADMINISTRATION
........................................................................................................................
10
OVERDOSAGE
..........................................................................................................................................................
12
ACTION AND CLINICAL PHARMACOLOGY
......................................................................................